肿瘤预防与治疗2024，Vol.37Issue(12)：1055-1060,6.DOI:10.3969/j.issn.1674-0904.2024.12.006
HR+HER2+青年男性乳腺癌1例暨文献回顾
HR+HER2+Breast Cancer in a Young Male:A Case Report and Litera-ture Review
摘要
Abstract
Given the rarity of male breast cancer(MBC)worldwide,this study presents a real-world case of a young man with locally advanced HR+HER2+breast cancer and axillary lymph node involvement who received neoadjuvant chemother-apy with TCbHP,exploring the application potential of TCbHP neoadjuvant therapy in MBC.A 31-year-old patient underwent six cycles of TCbHP as neoadjuvant therapy followed by a modified radical mastectomy without postoperative recurrence,demonstrating that TCbHP neoadjuvant therapy has a certain effect in MBC,although its outcomes may differ from those ob-served in female breast cancer.This case report contributes real-world evidence for the use of TCbHP in MBC,and highlights the need for targeted research on specific populations to investigate personalized treatment strategies.In addition,increasing public awareness of MBC,implementing early screening programs,and ensuring timely diagnosis and treatment are critical components for improving the prognosis of MBC patients.Acknowledging the limitations of single-case reports,future studies should include larger cohorts to validate these findings.关键词
男性乳腺癌/新辅助治疗/TCbHPKey words
Male breast cancer/Neoadjuvant therapy/TCbHP分类
医药卫生引用本文复制引用
杨文,张淅濛,宋海平..HR+HER2+青年男性乳腺癌1例暨文献回顾[J].肿瘤预防与治疗,2024,37(12):1055-1060,6.基金项目
This study was supported by Natural Science Foundation of Hubei Province(No.2024AFB081). 2024年湖北省自然科学基金计划(青年项目)(编号:2024AFB081) （No.2024AFB081）
